勘误：莱特。依洛尤单抗降低低密度脂蛋白胆固醇及动脉粥样硬化性心血管疾病二级预防的综述。心血管医学评论。2024年；25: 190。
Erratum: Leiter . Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease. Reviews in Cardiovascular Medicine. 2024; 25: 190.
作者信息
Leiter Lawrence A, Hegele Robert A, Brown Vivien, Bergeron Jean, Mackinnon Erin S, Mancini G B John
机构信息
Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON M5S 1A8, Canada.
Departments of Medicine and Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada.
出版信息
Rev Cardiovasc Med. 2024 Oct 24;25(10):383. doi: 10.31083/j.rcm2510383. eCollection 2024 Oct.
Abstract
[This corrects the article DOI: 10.31083/j.rcm2505190.].
摘要
[本文更正文章DOI：10.31083/j.rcm2505190。]
Zotero 插件